Methods for inhibiting phosphate transport
AssigneeArdelyx, Inc.
InventorAndrew J. King
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods for lowering serum phosphate in a mammal comprising administering an epithelial phosphate transport inhibitor, such as an NHE3 inhibitor, in combination with a phosphate binder as well as pharmaceutical compositions comprising such epithelial phosphate transport inhibitors and phosphate binders.
Claims16
A method for lowering serum phosphate in a patient comprising administering an effective amount of an epithelial phosphate transport inhibitor in combination with a phosphate binder, wherein the amount of the phosphate binder administered is less than the amount that would be administered as a single agent.
A pharmaceutical composition comprising an epithelial phosphate transport inhibitor and a phosphate binder, wherein the amount of the phosphate binder administered is less than the amount that would be administered as a single agent.
Dependencies are inferred from the claim text.